FMT
NTLA icon

First Mercantile Trust’s Intellia Therapeutics NTLA Stock Holding History

First Mercantile Trust’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$111K Buy
827
+327
+65% +$49.5K 0.01% 624
2021
Q2 		$81K Buy
+500
New +$38.9K 0.01% 741

Other funds holding NTLA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

First Mercantile Trust's NTLA Position: Q3 2021 in Review

First Mercantile Trust increased its Intellia Therapeutics (NTLA) stake by 65% in Q3 2021, buying an estimated $49.5K and bringing the position to 827 shares worth $111K. The position accounts for 0.01% of the portfolio, ranked #624.

First Mercantile Trust first reported a position in NTLA in Q2 2021 and has held it in 2 quarters since. 364 funds tracked by Wall St. Rank hold NTLA as of Q3 2021.

  • First Mercantile Trust held 827 shares of Intellia Therapeutics worth $111K as of Q3 2021.
  • First Mercantile Trust bought 327 Intellia Therapeutics shares in Q3 2021, an estimated $49.5K.
  • Intellia Therapeutics made up 0.01% of First Mercantile Trust's portfolio in Q3 2021, its #624 holding.
  • First Mercantile Trust first reported a position in Intellia Therapeutics in Q2 2021 and has held it in 2 quarters since.
  • 364 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q3 2021.

Based on First Mercantile Trust's 13F filing for Q3 2021, filed 24 Nov 2021.